LSP and Atlantic Bridge, two investment firms, led a $25m Series B funding round in Neurent Medical, a chronic inflammatory sino-nasal diseases treatment provider, with participation from Fountain Healthcare Partners. “We are dedicated to nurturing and growing companies with the potential to have a meaningful impact on society, and Neurent Medical is aligned with this mission. The company, with its strong team and pioneering technology, is well-placed to succeed in making a significant difference for the millions of people suffering with chronic rhinitis,” Drew Burdon, LSP Investment Manager.